1[1]Ikehara S,Good R A,Nakamura T,et al.Rationale for bone marrow transplantation in the treatment of autoimmune diseases[J].Proc Natl Acad Sci USA, 1985,82(12):2483.
2[2]Jacobs P, Vincent M D,Martell R W.Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplant[J]. Bone Marrow Transplant, 1986,1(1):237.
3[3]Marmont A M.Stem cell transplantation for severe autoimmune disease:progress and problems[J].Haematologica, 1998,83(8):733.
4[4]Ikehara S.Bone marrow transplantation for autoimmune disease[J]. Acta Haematol, 1998,99(3):116.
5[5]Khouri I,Lee M S,Palmer L, et al.Transplant-lite using fludarabine- cyclophosphamide and allogeneic stem cell transplantation for low grade lymphoma[J]. Blood,1999,94(3)1553.
6[6]Thomas E D.Bone marrow transplantation for malignant disease[J]. J Clin Oncol,1983,1(1):517.
8[8]Keever C A,Small T N,Flomenberg N,et al.Immune reconstitution following bone marrow transplantation:comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts[J]. Blood,1989,73(6):1340.
9[1]Bombardier C,Gladman DD,Urowitz MB,et al.Derivation of the SLEDAI:a disease activity index for lupus patients.Arthritis Rheum,1992,35:630-640.
10[2]Baldwin JL,Storb R,Thamas ED,et al.Bone marrow transplantation in patients with gold-induced marrow aplasa.Arthritis Rheum,1977,20:1043-1048.
